Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• 18 years and older

• Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent

• Able to understand, speak, read, and write in English

• Patients who have undergone hysterectomy, or plan to have a hysterectomy

• Patients who are transgender and gender diverse

Locations
United States
Minnesota
University of Minnesota
RECRUITING
Minneota
Contact Information
Primary
Maria Bunch
obgynresearch@umn.edu
612-624-2018
Time Frame
Start Date: 2025-06-30
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 40
Treatments
Standard of Care Cancer Screening
FDA approved self swab
Mock self swab
Sponsors
Leads: University of Minnesota

This content was sourced from clinicaltrials.gov